An Autoimmune Protocol Diet Improves Patient-Reported Quality of Life
Here are the results of another sub-study conducted under the original AIP medical study on the Autoimmune Protocol and inflammatory bowel disease (Crohn’s and ulcerative colitis), published by the journal Crohn’s & Colitis 360, and available for everyone to read for free!
If you’d like to read the full article now, you can find it here.
What was the focus of this study?
This study focused on 13 participants who were part of the original AIP IBD study and who all had active Crohn’s or ulcerative colitis. During the study process they completed the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) via an online survey portal, with data collected at baseline, and weeks 3, 6, 9, and 11. The SIBDQ measures patient-reported quality of life.
What were the results of this study?
The big, simple answer is that quality of life improved dramatically! Here are some highlights on what was found:
- Among participants completing all 5 surveys, mean SIBDQ increased from 46.5 to 61.5 by week 11.
- As early as week 3, participants experienced significant improvements in bowel movement frequency, stress, and ability to perform leisure/sport activities.
- Overall adherence rate to AIP was 73.3% at week 6.
- The clinical benefits seen were experienced regardless of IBD medication use.
To learn in-depth about the study methods, measures, analysis, and results, you can access the full article here.
What does this mean?
This study shows that it’s possible for AIP to meaningfully improve quality of life for those with an autoimmune disease or an autoimmune response. Autoimmune disease healthcare providers often tell us we “have to learn to live this way.” Great news, right!?